In addition, FDA is proposing two other constraints around the submission of the supplemental PMTA. Beneath proposed § 1114.15(a), a supplemental PMTA couldn't be submitted exactly where the advertising and marketing order for the initial tobacco products is withdrawn or continues to be quickly susp